Date:  This activity was pre-recorded on January 14, 2020 from 1:00PM – 2:00PM ET. Participants must review the activity, complete the post-test AND evaluation in its entirety to receive credit for this activity.

*This home study was released on February 1, 2020. Each user has 365 days of access post-purchase OR its expiration date February 1, 2023, whichever occurs first.

Cost: $9 for ASCP Members, $18 Non-Members

Speaker:
Alan Obringer, RPh, CPh
President/Owner
Guardian Pharmacy of Orlando

Financial Disclosure:
Alan Obringer discloses no relevant financial conflicts of interest with regard to this activity.

Target Audience:
Any practicing pharmacist, whether in a clinical or dispensing role should participate in this webinar as the new policies affect consultant pharmacists just as much as others in practice.

Learning Objectives:
At the conclusion of this application-based activity, participants should be able to:

• List federal requirements regarding the prescribing and dispensing of opioids.
• Apply the laws and rules related to the prescribing and dispensing of controlled substances,
• including opioids.
• List the differences, similarities and challenges between being a solo LTC pharmacist in practice
• vs. having a group and larger practice across states.

How to Earn Credit:
Post-Test: You will have unlimited attempts to achieve a 70% or higher on the post-test assessment.

CPE Credit: Please note: you must complete the post-test and evaluation within 365 days post-purchase or by its expiration date February 1, 2023 at 11:59pm ET to receive credit. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website PRIOR to course completion.

Please see computer hardware/software requirements  here.